Health

    Pandemics & Infectious Diseases

    Medical Treatment & Drug Development

    Antimicrobials, Antibiotics & Drug Resistances

AXA Projects

France

Effects of subinhibitory concentrations of antibiotics on the emergence of antibiotic resistance

To add or modify information on this page, please contact us at the following address: community.research@axa.com

Ivan
MATIC

Institution

Institut National de la Santé et de la Recherche Médicale

Genetics and Development Institute

Country

France

Nationality

French

ORCID Open Researcher and Contributor ID, a unique and persistent identifier to researchers

Related articles

Health

Chronic & Non Communicable Diseases

Medical Treatment & Drug Development

Chronic Pain & Musculoskeletal Disorders

Drug Delivery

Biotech- and Nanotechnology

AXA Project

France

Pain Pediatric & Elderly AXA Research Lab (PEARL)

Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more

Celine
GRECO

Hôpital Necker-Enfants Malades

Health

Medical Treatment & Drug Development

Drug Delivery

Biotech- and Nanotechnology

Mécénat des Mutuelle

France

Accelerating drug innovation with the Euridis school and its DDD Challenge

The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more

Laurence
SABATIER

Institut du médicament de Strasbourg

Health

Mental Health & Neurology

Prevention & Personalised Health

Medical Treatment & Drug Development

Alzheimer's Disease, Dementia & Neurodegenerative Diseases

Brain Mechanisms & Psychology

Genetics & Omics

Diagnosis & Imaging

Mécénat des Mutuelle

France

Towards personalized medicine in Parkinson's disease

The project led by Christine Brefel-Courbon aims to study the impact of personality as a key component of personalized medicine,... Read more

Christine
BREFEL-COURBON

INSERM